Point-of-care diagnostic documentation requires flawless accuracy in IVD instructions, clinical protocols, and regulatory submissions. Writers must distinguish analytical sensitivity from clinical specificity while maintaining clarity for laboratory technicians and healthcare providers.

Our assessments evaluate candidates' command of CLIA terminology, ISO 13485 standards, and IVDR compliance language. The test predicts on-the-job performance by measuring ability to communicate assay characteristics, detection limits, and quality control procedures accurately.

Illustrative scenario

Glucose Meter Instructions Mix-Up Triggers Field Safety Notice

A technical writer confused 'control solution' with 'calibration solution' in glucose meter user instructions, leading to incorrect QC procedures. The company issued a field safety notice to 15,000 healthcare facilities and faced a six-month FDA investigation.

A composite example of a failure mode that is common in Point Of Care Diagnostics. It is not an account of a real client engagement and no real organisation is described.

Documents You'll Be Testing

Instructions for Use (IFU)
Clinical Evaluation Reports
510(k) Predicate Comparisons
Quality Control Protocols
Analytical Validation Studies
IVDR Technical Documentation

Avoid These Common Editorial Mistakes

Confusing analytical sensitivity with clinical sensitivity

Incorrect performance claims in regulatory submissions leading to FDA questions or rejection

Misidentifying CLIA complexity categories

Inappropriate market positioning and compliance violations in laboratory settings

Incorrect specimen handling instructions

Pre-analytical errors causing false results and potential patient harm

Wrong regulatory pathway identification

Delayed market entry due to inappropriate FDA submission route selection

Mixing up control and calibration materials

Incorrect quality control procedures and potential laboratory accreditation issues

Master These Key Terms

Analytical sensitivity vs Clinical sensitivity
Limit of detection vs Limit of quantitation
Control solution vs Calibration solution
Clinical cut-off vs Analytical cut-off
De Novo pathway vs 510(k) pathway

Smart Hiring Strategies

Prioritise candidates who understand CLIA complexity categories and can differentiate analytical from clinical validation. Look for expertise in ISO 15197 standards, lateral flow terminology, and FDA pathway requirements including specimen collection protocols.

POCT writers navigate stringent regulatory frameworks where terminology errors in assay specs or clinical claims risk compliance failures. Poor editing can delay market access, compromise patient safety, and trigger expensive field corrections or device recalls.

Frequently Asked Questions

What makes point-of-care diagnostics writing different from general medical device writing? ↓
POCT writing requires expertise in both laboratory procedures and clinical applications. Writers must understand CLIA regulations, assay chemistry, and how results guide patient care decisions. The terminology is highly specialized with strict regulatory requirements for accuracy.
Should I test candidates on FDA and European regulatory knowledge? ↓
Yes, both FDA 510(k) and IVDR pathways have specific documentation requirements and terminology. Candidates should understand different submission routes, performance evaluation requirements, and how regulatory language differs between markets for the same device.
How technical should our writers be for point-of-care diagnostics? ↓
Writers need sufficient technical depth to understand assay principles, performance characteristics, and clinical applications. They should grasp concepts like cross-reactivity, matrix effects, and clinical validation without necessarily having laboratory bench experience.
What's the biggest risk of poor writing in this field? ↓
Incorrect instructions or unclear procedures can lead to user errors affecting patient diagnosis and treatment. Regulatory documentation errors can delay market access or trigger compliance actions, while poor clinical claims can result in FDA enforcement.
Do candidates need experience with specific diagnostic technologies? ↓
While helpful, technology-specific experience is less important than understanding general POCT principles, regulatory requirements, and clinical applications. Strong candidates can adapt their skills across immunoassays, molecular diagnostics, and other point-of-care platforms.